Human ovarian adenocarcinoma cells synthesize vitronectin and use it to organize their adhesion

被引:46
作者
Carreiras, F
Cruet, S
Staedel, C
Sichel, F
Gauduchon, P [1 ]
机构
[1] INSERM, CJF 96 03, Expt Cancerol Lab, F-14076 Caen 05, France
[2] Ctr Francois Baclesse, GRECAN EA 1772, F-14076 Caen 05, France
[3] CNRS, Fac Pharm Marseille, ESA 6032, F-13385 Marseille 5, France
关键词
D O I
10.1006/gyno.1998.5262
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Extracellular matrix components and integrin receptors are frequently altered in cancer, including ovarian adenocarcinoma. Vitronectin (Vn) is a matrix protein mainly synthesized by liver cells; it is present in normal ovarian surface epithelium and differentiated ovarian adenocarcinoma, but is frequently undetectable in undifferentiated carcinoma (F. Carreiras et al., 1996, Gynecol Oncol 62:260-267). Wondering about the cellular origin of Vn in ovarian carcinoma, we searched for evidence of Vn synthesis by these tumors. We demonstrated that three human ovarian adenocarcinoma cell lines were able to synthesize Vn, as revealed by the presence of Vn mRNA and the protein. The Vn matrix promotes adhesion of ovarian tumor cells through Mi integrins. Moreover, during in vitro growth, Vn is progressively organized into a particular pattern in combination with the recruitment of ay into focal contacts. Our results suggest that Vn synthesis may participate in ovarian adenocarcinoma cell biology and raise the possibility that altered expression of Vn in some ovarian carcinomas could result from a defect in Vn synthesis, (C) 1999 Academic Press.
引用
收藏
页码:312 / 322
页数:11
相关论文
共 45 条
[1]  
ALBELDA SM, 1993, LAB INVEST, V68, P4
[2]  
BARTOLAZZI A, 1993, ANTICANCER RES, V13, P1
[3]  
Bjorge L, 1997, INT J CANCER, V70, P14, DOI 10.1002/(SICI)1097-0215(19970106)70:1<14::AID-IJC3>3.0.CO
[4]  
2-9
[5]   POLARIZATION OF THE ALPHA-6-BETA-4 INTEGRIN IN OVARIAN CARCINOMAS [J].
BOTTINI, C ;
MIOTTI, S ;
FIORUCCI, S ;
FACHERIS, P ;
MENARD, S ;
COLNAGHI, MI .
INTERNATIONAL JOURNAL OF CANCER, 1993, 54 (02) :261-267
[6]   EXPRESSION AND FUNCTION OF BETA-1 AND ALPHA-V-BETA-3 INTEGRINS IN OVARIAN-CANCER [J].
CANNISTRA, SA ;
OTTENSMEIER, C ;
NILOFF, J ;
ORTA, B ;
DICARLO, J .
GYNECOLOGIC ONCOLOGY, 1995, 58 (02) :216-225
[7]   Expression and localization of alpha v integrins and their ligand vitronectin in normal ovarian epithelium and in ovarian carcinoma [J].
Carreiras, F ;
Denoux, Y ;
Staedel, C ;
Lehmann, M ;
Sichel, F ;
Gauduchon, P .
GYNECOLOGIC ONCOLOGY, 1996, 62 (02) :260-267
[8]   IMPLICATION OF THE ALPHA-V-BETA-3 INTEGRIN IN THE ADHESION OF THE OVARIAN-ADENOCARCINOMA CELL-LINE IGROV1 [J].
CARREIRAS, F ;
LEHMANN, M ;
SICHEL, F ;
MARVALDI, J ;
GAUDUCHON, P ;
LETALAER, JY .
INTERNATIONAL JOURNAL OF CANCER, 1995, 63 (04) :530-536
[9]  
CARREIRAS F, IN PRESS INT J CANC
[10]   PLASMINOGEN ACTIVATORS AND PLASMINOGEN-ACTIVATOR INHIBITORS IN BLOOD AND TUMOR FLUIDS OF PATIENTS WITH OVARIAN-CANCER [J].
CASSLEN, B ;
BOSSMAR, T ;
LECANDER, I ;
ASTEDT, B .
EUROPEAN JOURNAL OF CANCER, 1994, 30A (09) :1302-1309